Looking Back, Looking Forward
A KidneyCAN Town Hall Event
Renowned clinical kidney cancer researchers shared a retrospective of 2022 breakthroughs, along with a look forward at what we can expect in 2023, at our recent Town Hall event.
Watch below if you missed the live webinar!
Watch as leading experts share the most promising 2022 kidney cancer research, as well as expectations for 2023.
If you are interested in hearing about more events like this, make sure you’re subscribed to our newsletter.
2022 Research Retrospective
Dr. Rana McKay, M.D.
UC San Diego Health Center
Looking Forward to 2023 Research
Dr. Hans Hammers, M.D., Ph.D.
UT Southwestern Medical Center
Resource Links from Topics Mentioned in the Program
Here are links to detailed information about the trials Dr. McKay included in her presentation. If you are discussing one of these combinations with your oncologist, you’ll find a detailed take-home reference here.
Frontline Therapy for Advanced Kidney Cancer
Non Clear Cell
Here are links to the trials mentioned by Dr. Hammers during his presentation:
XL-092 with Immuno-Oncology Agents in Solid Tumors (Stellar2)
HIF Inhibitor Trials:NKT2152 and ARO-HIF2
An informed patient is an empowered patient.
We at KidneyCAN know how challenging it can be to keep up with research developments and how they could impact your treatment options. We hope the ideas presented in our Town Hall help you as you work with your doctor to manage your care for kidney cancer.
If you’re looking to connect with more people who share your challenges and can offer support, check out our Smart Patients forum.
This event supported by:
Join Our Grassroots Army
Our mission is to #AccelerateCures for #KidneyCancer. Join our #GrassrootsArmy. We need you!